Processing Magazine

Pfizer completes $81 million Puerto Rico expansion

September 20, 2005

The Associated Press reports that U.S. pharmaceutical giant Pfizer Inc. has completed a US$81 million (euro66 million) expansion of two plants in northern Puerto Rico, the governor said. The expansion will allow the company to produce three new drugs at its plants in Vega Baja and Barceloneta, Gov. Anibal Acevedo Vila said at an inauguration ceremony Friday, September 16. Pfizer will produce the antibiotic Zmax and the epilepsy drug Lyrica at a new 27,000-square-foot facility in Vega Baja, while a new facility in Barceloneta will make the anti-insomnia drug Indiplon, Acevedo Vila''s office said in a statement. New York-based Pfizer''s current investment in Puerto Rico totals US$2.2 billion (euro1.8 billion). The drug maker employs some 4,300 people at its five plants in the U.S. Caribbean territory. The pharmaceutical industry accounted for 25.8 percent of Puerto Rico''s gross domestic product in 2004, Acevedo Vila said.